Category:Alan Shuldiner of Tarrytown NY (US)

From WikiPatents
Jump to navigation Jump to search

Alan Shuldiner of Tarrytown NY (US)

Executive Summary

Alan Shuldiner of Tarrytown NY (US) is an inventor who has filed 3 patents. Their primary areas of innovation include {against enzymes (viral enzymes (2 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (1 patents), and they have worked with companies such as Regeneron Pharmaceuticals, Inc. (3 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

Alan Shuldiner of Tarrytown NY (US) Monthly Patent Applications.png

Technology Areas

Alan Shuldiner of Tarrytown NY (US) Top Technology Areas.png

List of Technology Areas

  • C12N15/1137 ({against enzymes (viral enzymes): 2 patents
  • A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
  • A61P19/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • C12Q1/6874 (involving nucleic acid arrays, e.g. sequencing by hybridisation): 1 patents
  • C12N9/0006 (Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth): 1 patents
  • A61K38/443 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K38/465 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K47/61 (the organic macromolecular compound being a polysaccharide or a derivative thereof): 1 patents
  • A61P1/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N9/96 (Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates): 1 patents
  • C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 1 patents
  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
  • C12N15/85 (for animal cells): 1 patents
  • C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12Q1/32 (involving dehydrogenase): 1 patents
  • C12Q1/6827 (for detection of mutation or polymorphism): 1 patents
  • C12Q1/6876 (Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes): 1 patents
  • C12Q1/6883 (for diseases caused by alterations of genetic material): 1 patents
  • C12Y101/01051 (ENZYMES): 1 patents
  • C12Y101/01062 (ENZYMES): 1 patents
  • G01N33/5067 (Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes): 1 patents
  • A61K48/0066 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
  • C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2310/531 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2320/34 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
  • A61K31/137 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K31/165 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61P3/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents

Companies

Alan Shuldiner of Tarrytown NY (US) Top Companies.png

List of Companies

  • Regeneron Pharmaceuticals, Inc.: 3 patents

Collaborators

Subcategories

This category has the following 2 subcategories, out of 2 total.

A

Retrieved from "http://wikipatents.org/index.php?title=Category:Alan_Shuldiner_of_Tarrytown_NY_(US)&oldid=180858"